patients had increased NO,-concentrations, with most of the superfluous salivary NO being produced not by the immigrant inflammatory cells, but rather, by the resident salivary gland cells. NO may contribute to inflammatory damage and acinar cell atrophy in SS.
Nitric oxide (NO) is produced by vascular endothelium, nerve terminals, and inflammatory cells in a reaction catalyzed by NO synthase (NOS), which converts L-arginine to NO and L-citrulline (1) . NOS occurs in at least 3 different isoforms, endothelial constitutive NOS (ecNOS), neuronal constitutive NOS (ncNOS), and inducible NOS (iNOS) (2,3). Both ecNOS and ncNOS are constitutively expressed, but are regulated as to their level of activity by various soluble ligands and/or shear forces through calcium/calmodulin-dependent second messenger pathways. NO concentrations produced by this route are usually relatively low (in the picomolar range). In contrast, regulation of iNOS occurs at the level of gene transcription and is relatively slow, but leads to long-lasting and significant increases in NO production (giving rise to nanomolar local concentrations of NO) (1,3,4).
NO has a short half-life and is rapidly converted to nitrites and nitrates. Therefore, its range of action is limited. This is important from the point of view of regulation, because NO itself is a small, lipid-soluble compound, which easily penetrates the cell membrane of nearby cells and can therefore affect them in a receptorindependent autocrine and/or paracrine manner. At the same time, NO is a highly reactive compound, due to an unpaired electron in its molecular orbital. At low concentrations, it preferentially activates guanylate cyclase, which thus produces cGMP. At high concentrations, NO inhibits various iron-containing DNA synthetases and mitochondria1 enzymes, and thus inhibits cell growth and division, finally leading to cell death (5).
Due to its potential dual role in normal salivary gland function and damage in pathologic conditions, it was considered important to characterize the eventual presence of NO in saliva and to localize the cells/NOS isoforms responsible for NO production in patients with Sjogren's syndrome (SS).
PATIENTS AND METHODS
Patients and samples. All patients and healthy volunteers gave their informed consent. The Declaration of Helsinki (6) was followed throughout the study, which was approved by the local ethics committee.
Both patients and controls provided a stimulated salivary sample, as described elsewhere (7) . Briefly, stimulation of saliva was achieved by the chewing of paraffin for 5 minutes, and the stimulated whole saliva was then collected. Immediately after collecting the saliva, the samples for NO2-measurement were centrifuged at 1, OOOg for 5 minutes, and the supernatants were frozen at -70°C until analyzed. For vasoactive intestinal peptide (VIP) measurement, the saliva was collected into chilled tubes containing 50,000 IU/ml aprotinin and 10 m M EDTA to minimize artifactual neuropeptide degradation in vitro (8) .
The mean age of the 12 primary S S patients, who were all women, was 51.6 years (range 21-74). The duration of the SS was a mean of 9 years (range 1-23). All patients were nonsmokers. The mean age of the 10 healthy control women was 47.7 years (range 39-56).
The dental/periodontal features of all patients were evaluated for decayed, missing, or filled surfaces using the DMFS index (9), bleeding on probing using the BOP index (lo), presence of visible plaque using the visible plaque index (1 l), retentive calculus (subgingival calculus) using the RC index (12) , items on the community periodontal index of treatment needs (13) , and pocket probing depth (10) . Eventual correlations were sought between the dental and periodontal status and salivary NO,-concentration.
Between 6 and 8 labial salivary glands (LSGs) were obtained from each patient by biopsy. Samples were taken by blunt dissection under infiltration anesthesia and fixed by immersion in freshly made 1% paraformaldehyde in 0.01M phosphate buffered 0.15M saline (PBS; pH 7.1) at 4°C for 16-18 hours. After fixation, cryoprotection was performed in 15% (weight/volume) sucrose and 0.01% (w/v) sodium azide in PBS for several days at 4°C before the samples were embedded in Tissue-Tek OCT compound (Lab-Tek Products, Elkhart, IN), snap frozen in liquid nitrogen, and stored at -70°C until staining. LSGs were obtained from 4 patients with S S who fulfilled the European criteria for SS (14) , and from 2 healthy controls who did not have SS (14) and who had a focus score of <1 (15) .
Jenkins activity survey (JAS). The JAS scale consists of 84 items, which are divided into 4 subscales. For the present study, we recorded the values of the actual A-B factor, which involves 21 items on the JAS that best reflect the stress behavior of a person (16) . The reliability of the stress factor was confirmed with the use of the Cronbach a test (17) .
Nitrite analysis. NO,-, a stable end-product of NO oxidation, was measured using the Griess reagent, consisting of equal volumes of 0.1% N-(1-naphthy1)ethylenediamine HCI and 1% sulfanilamide plus 5% H,PO, (18) . Briefly, 5O-pI aliquots of the saliva sample, in duplicate, from each donor were incubated with an equal volume of the Griess reagent in a 96-well U-bottomed microtiter plate for 5 minutes at 22°C. With each study, a standard curve was established using NaNO, in a range of 10-1,000 for each assay. After a 10-minute reaction, the microplate was read on a spectrophotometer at 545 nm. The data were derived from the slope of the standard curve and were presented as the mean value of the duplicates. Results of the salivary NO2-measurements were expressed as a concentration (in pM), but also as NO2-output (output = concentration x volume; in nmoles/minute).
NADPH-diaphorase histochemical analysis. For histochemical demonstration of NADPH-diaphorase activity, which is an indicator of NOS activity, freshly cut and PBS-rinsed 10-pm cryostat sections from the midsagittal plane of LSGs were mounted on formol-gelatin-coated slides and incubated in 1 mM p-NADPH, 0.5 mM nitroblue tetrazolium, 1.5 mM L-malic acid, and 0.1% Triton X-100 in 50 mM Tris HCl, pH 7.4, at 37°C for 1 hour. Finally, slides were rinsed in distilled water and mounted (19) . This procedure resulted in an intense deep-blue nitroblue tetrazolium formazan formation, which was not observed when NADPH was not added to the reaction mixture.
Acetylcholinesterase histochemical analysis. Acetylcholinesterase activity in LSG tissue was visualized as previously described (20) . Briefly, the cryostat sections were first immersed in an incubation medium for 45 minutes at 37°C. The acetylcholinesterase activity was then visualized by immersion of the sections for 5 minutes in 50 mMTris HCl buffer, pH 7.6, containing 0.04% 3,3'-diaminobenzidine and 0.3% nickel ammonium sulfate. Sections were incubated in this solution for a further 5 minutes after addition of hydrogen peroxide, for a final concentration of 0.003%.
Immunocytochemical analysis for NOS. Polyclonal antibodies for the cNOS and iNOS isoforms used in this study have been characterized in detail elsewhere. Briefly, antibodies for ncNOS, kindly provided by Drs. S. Moncada and V. Riveros-Moreno (Wellcome Research Laboratories, Beckenham, Kent, UK), were raised against the whole protein purified from rat brain and against synthetic peptide fragment 53 of rat brain ncNOS; both of these antisera cross-react with the ecNOS isoform at high concentrations (21) . Monoclonal antibodies for ecNOS were raised against a purified whole protein of particulate bovine aortic endothelial NOS isoform (22) and were kindly provided by Dr. J. S. Pollock (Abbott Laboratories, Abbott Park, IL). Antibodies for iNOS were raised against synthetic peptides corresponding to amino acid residues 47-71 of murine macrophage iNOS and 54-76 of human hepatocyte iNOS (23) (24) (25) . Murine macrophage iNOS antibodies were kindly provided by Drs. S . Moncada and V. Riveros-Moreno (Wellcome Research Laboratories) and human hepatocyte iNOS antibodies by Dr. T. J. Evans (Royal Postgraduate Medical School).
Antibodies against the synthetic 47-71 peptide of macrophage iNOS have been characterized for specificity in detail elsewhere, with the use of an antigen preabsorption test and Western blotting (25) . Similarly, the specificity of the human hepatocyte iNOS antibodies have been confirmed by antigen reabsorption test with the use of a synthetic 54-76 peptide, by Western blotting, and by comparison with in situ hybridization (26) . There was no cross-reactivity between ecNOS and iNOS antibodies.
Antibodies against tumor necrosis factor a (TNFa; Dr. W. A. Buurman, University of Limburg, Maastricht, The Netherlands) and CD68 (Dako, Glostrup, Denmark) were used to demonstrate a possible induction mechanism of iNOS and its localization in macrophages. Antibodies against CD31 (platelet endothelial cell adhesion molecule; Dr. A. V. Mazurov, Institute of Experimental Cardiology, Cardiology Research Centre, Moscow, Russia) and against nitrotyrosine (TCS Biological, Bucks, UK) were used, in some cases, to demonstrate endothelial cells and the possible site of action of oxidative NO-induced damage in inflammatory LSG tissue, respectively.
Fifteen micrometer-thick cryostat sections were cut through the midsagittal planes of LSGs, transferred onto formol-gelatin-coated slides, and allowed to dry for 1 hour before any further procedures were carried out. Endogenous peroxidase was inhibited by soaking the sections in 0.3% (v/v) hydrogen peroxide in methanol at 4°C for 20 minutes. The sequential sections were then placed in a humid chamber and incubated 1) overnight at 4°C with primary antibodies as described above; 2) for 30 minutes at 22°C with biotinylated goat anti-rabbit (for polyclonal antibodies) or horse antimouse (for monoclonal antibodies) IgG (Vector Laboratories, Peterborough, UK), diluted 1:lOO in PBS with 0.1% w/v bovine serum albumin; and 3) for 60 minutes at 22°C with avidinbiotin-peroxidase complex (ABC; avidin and biotinylated horseradish peroxidase diluted 1:200 in 0.1M PBS, pH 7.4 [27] , for 5 minutes at 22°C with 3,3'-diaminobenzidine and nickel ammonium sulfate containing glucose and glucose oxidase). After each step, the slides were rinsed 3 times in PBS for 5 minutes. Finally, the slides were dehydrated in ethanol, cleared in Inhibisol (Kalon Chemicals, Cramlington, UK), and mounted in Pertex (Histolab Products, Gothenburg, Sweden).
Omission of the primary antibodies and use of irrelevant immunoglobulin from the same species and of the same class, isotype, and concentration were used as staining controls. Conventional hematoxylin and eosin staining of sequential sections was used for comparative histopathologic analysis.
Other immunohistochemical analyses. VIP immunolocalization was performed using specific antibodies and the ABC technique, as described in detail elsewhere (28, 29) . All samples were also stained with anti-CD31, anti-CD68, and antimyeloperoxidase antibodies as markers for endothelial cells, macrophages, and neutrophils, respectively. Furthermore, all samples were similarly assessed for the presence, localization, and extent of expression of TNFa.
An indirect immunofluorescence method was used for colocalization of iNOS and CD68-positive macrophages. Cryostat sections, 7-10-pm thick, mounted on formol-gelatincoated slides, were washed in PBS and incubated with 1) diluted normal goat serum for 30 minutes at 22°C before blotting it away; 2) monoclonal anti-CD68 antibodies for 16 hours at 4°C; 3) tetramethylrhodamine isothiocyanate (TR1TC)-labeled goat anti-mouse IgG antiserum (1: 100) for 60 minutes at 22°C in the dark; 4) polyclonal iNOS antibodies (1:300) for 16 hours at 4°C in the dark; and 5) fluorescein isothiocyanate (F1TC)-labeled goat anti-rabbit IgG (1:lOO) for 60 minutes at 22°C in the dark before mounting with Vectashield (Vector Laboratories) to reduce quenching of the Cell counting. The total number of CD68-positive macrophages and cells immunoreactive for the murine and human iNOS antibodies were counted manually using a graticule and a 20X objective magnification. Four randomly selected fields which contained at least 1 inflammatory cell focus with more than 50 inflammatory mononuclear cells were counted in each study subject. The cells that were counted included inflammatory cells, acinar cells, and some ductal epithelial cells. Cells with typical mast cell morphology were excluded from cell counts.
Radioimmunoassay for VIP. The neuropeptide concentration in saliva was measured using a standard competitive '251-radioimmunoassay kit (Peninsula, Belmont, CA) as described in detail elsewhere (8) . Briefly, 1) 100 p1 of sample or standard was incubated in polypropylene tubes for 24 hours at 4°C with 100 pl of rabbit anti-human VIP IgG, 2) 100 p1 of 1251-labeled peptide (10,000-15,000 counts per minute/100 pl) was added and incubated for 24 hours at 4"C, 3) 100 pl of goat anti-rabbit IgG and 100 pl of normal rabbit serum were added and incubated for 90 minutes at room temperature before 4) 500 pl of radioimmunoassay buffer was added, followed by centrifugation at 1,700g for 20 minutes at 4°C. The supernatant was discarded and the radioactivity of the pellet was measured with a programmed gamma scintillation counter. All samples were analyzed in duplicate, with individual controls for apparent binding in the absence of antibody (i.e., total counts, nonspecific binding, total binding).
Statistical analysis. Results are presented as the mean ? SEM. Comparisons between the 2 groups were performed with the Student's t-test for normally distributed variables, and with the Mann-Whitney U test for non-normally distributed variables. For analysis of the linear relationship between 2 variables, Pearson's correlation coefficient was used for normally distributed variables and Spearman's rank correlation coefficient for non-normally distributed variables. BMDP-PC, version 7.01 (BMDP Statistical Software, Cork, Ireland), statistical software was used for all calculations except for those in the JAS, which were analyzed using the SPSS software package (SPSS Inc., Chicago, IL).
RESULTS
Relationship of salivary NO,-to SS, stress, and VIP. The NO,-concentration was higher in patients with SS (mean 2 SEM 307 2 51 CLM) than in healthy control individuals (97 ? 16 pA4; P < 0.05). There was no correlation between the salivary NO2-concentration and the dental or periodontal status of the SS patients ( Table 1 ). The NO2-output was 37.2 f-6.6 nmoles/ minute in healthy controls compared with 166.3 i 46.2 nmoles/minute in patients with SS (P < 0.01). The salivary VIP concentration was 68.6 i 24.2 pg/ml in the patient group compared with 40.8 t 23.6 pg/ml in the healthy control group (P < 0.05). However, there were no significant correlations between salivary NO2-and VIP concentrations or between salivary NO2-concentration and stress in the patients or in the controls.
NADPH-diaphorase activity in LSGs in SS.
The most conspicuous finding was that, in the LSGs, intense NADPH-diaphorase activity was localized in myoepithelial cells of the glandular acini and less frequently in acinar end-piece cells ( Figure 1A ). Epithelial cells of intercalated, striated, and excretory ducts also showed intense NADPH-diaphorase activity ( Figure 1A) . It was particularly interesting that such epithelial-cell NADPH-diaphorase expression was also seen in the LSGs obtained from healthy controls. NADPHdiaphorase activity was found in some nerve trunks, fibers, and terminals located around the acini and salivary ducts. Such NADPH-diaphorase-containing nerve fibers and terminals were relatively evenly distributed, but seemed to be absent from lymphocyte-infiltrated areas (i.e., lymphocyte foci) in SS patients.
NADPH-diaphorase activity was less frequently localized in endothelial cells of arterioles, capillaries, or venules. NADPH-diaphorase-positive endothelial cells were, in particular, observed in lymphocyte infiltrates in SS patients (for more details, see below). NADPHdiaphorase activity was seen in only a few of the inflammatory cells of the characteristic focal lymphocyte-rich foci (for more details, see below).
Neuronal cNOS in LSGs in SS. Antibodies raised against the whole ncNOS protein purified from rat brain and the synthetic peptide fragment 53 of rat brain ncNOS showed a very sparse distribution of ncNOScontaining nerve fibers, mainly localized around the acini and along the salivary ducts ( Figure 1B) . However, ncNOS immunoreactive nerve fibers were not seen in inflammatory cell foci in SS. In contrast, acetylcholinesterase histochemical and immunocytochemical localization of VIP-containing nerve fibers revealed a very dense distribution of cholinergic and VIPergic (parasympathetic) nerve fibers coiling around the acini and salivary ducts in noninflammed areas of LSG, although such fibers appeared to be mostly absent from the lymphocyte foci in SS (data not shown).
Endothelial cNOS in LSGs in SS. Monoclonal antibodies raised against the bovine aortic ecNOS isoform revealed a very sparse endothelial cell ecNOS immunoreactivity compared with immunoreactivity for CD31. However, it was of interest to note that in SS, CD31-positive endothelial cells in focal inflammatory cell infiltrates showed a strong immunoreactivity for ecNOS ( Figures 1C and D) . Some ductal epithelial cells showed dense granular immunoreactivity and many acini were also immunoreactive for this antiserum ( Figure 1E ).
Inducible NOS in LSGs in SS. Antibodies raised against both the murine macrophage and human hepatocyte iNOS peptide sequences were used in the present study. The 2 antibodies gave somewhat different profiles of iNOS-immunoreactive cells in inflammatory LSG tissue. Murine macrophage iNOS antiserum showed immunoreactivity for acinar structures and some inflammatory cells, whereas human hepatocyte iNOS antibodies showed more frequent immunoreactivity for mononuclear inflammatory cells ( Figure 1F ) as well as for some ductal epithelial cells (data not shown).
In SS patients, granular TNFa staining was seen in some acini, vascular endothelial cells, and, most notably, ductal epithelial cells. Immunostaining of serial sections for TNFa and human hepatocyte iNOS peptide sequence showed colocalization of TNFa with iNOS in ductal epithelial cells, but not in acinar or vascular endothelial cells (Figures 2A and B) .
The chemical reaction of NO with superoxide generates peroxynitrate, which has been shown to cause nitration of protein tyrosine groups. Antibodies against nitrosylated tyrosine (nitrotyrosine) residues labeled some ductal epithelial cells, but mainly detected nitrotyrosine in periductal connective tissue. Periacinar connective tissue was also, in some cases, nitrotyrosine positive, but nitrotyrosine immunoreactivity could not be detected within the acinar cells (data not shown). Nitrotyrosine-staining controls were negative.
Cell counting showed human hepatocyte iNOS in some immigrant inflammatory cells in the lymphocyterich foci in patients with SS. Approximately 16 ? 3 (mean 2 SEM) such cells were seen per 1 mm2 of Figure 2 . Immunoreactivity for human inducible nitric oxide synthase (iNOS) antibodies (A) (arrows) was found to colocalize with that for tumor necrosis factor a (TNFa) (B) (arrows) in ductal epithelial cells in labial salivary glands from patients with Sjogren's syndrome. The 2 sections immunostained for iNOS and TNFa were taken 40 pm apart, but several ducts can still be traced through the tissues. Note the absence of iNOS and TNFa immunoreactivity in acini. (Original magnification X 400.) inflammatory cells, compared with 21 2 2 CD68+ macrophages. However, colocalization studies with double labeling suggested that there was only a minor overlap between these 2 cell subpopulations (data not shown), although some CD68-positive macrophages were also immunoreactive for human hepatocyte iNOS (Figures 3A and B) . DISCUSSION SS is characterized by a focal adenitis, autoimmunity, and sicca symptoms. In salivary glands, this is expressed in the form of focal T lymphocyte-rich infiltrates and xerostomia. The simplistic and prevailing view has been that sialopenia and xerostomia are due to structural destruction of the secretory acinar cells, which are responsible for the secretion of the primary saliva. However, there is a clear discrepancy between the often focal and local salivary gland involvement and the greatly diminished salivary flow seen in SS. Significantly, many patients draw advantage from the use of sialogogues, such as xylitol gum or pilocarpine. Therefore, an alternative hypothesis has been that, before permanent salivary gland parenchymal damage has occurred in a long-lasting and chronic disease, the focal perivascular and periductal inflammation alters the vasoneural regulation of the various vascular, motor, and secretory components of the normal salivary flow.
Using VIP and neuropeptide Y as markers for postganglionic parasympathetic and sympathetic nerve fibers, respectively, a clearly decreased innervation of the salivary glands in SS has been shown (28,29) . In addition to adrenergic and cholinergic nerves, the nonadrenergic, noncholinergic system plays a role in normal and abnormal neuronal regulation of the salivary glands. An important part of the nonadrenergic, noncholinergic system is mediated by VIP, which, via its low-affinity binding sites, is linked to CAMP formation and, via its high-affinity binding sites, to Ca2+ mobilization and promotion of neuronal survival (30-32). More recently, NO has been measured in human saliva (33). It was also confirmed that NO is released from salivary glands rather than being produced from the activity of oral bacteria (33). Furthermore, there were no significant correlations between the salivary NOz-concentration and the periodontal status of the SS patients, which rules out any contribution of inflammatory gingival crevicular fluid to the salivary NO2-. This is consistent with recent studies on the presence of NADPH-diaphorase activity and NOS isoforms in feline submandibular glands (34) and with the current findings on the presence of NADPH-diaphorase activity and of all 3 different NOS isotypes in human salivary glands.
Formation of primary saliva involves vasodilation and acinar cell secretion. Changes in the regulatory vasoneural interactions may lead to sialopenia and dry mouth, such as is seen in psychogenic dry mouth in depression and anxiety or as an anticholinergic side effect of many widely used drugs. Changes in the L-arginine/NO-generating pathway may contribute to these crucial events. NO may influence parasympathetic vasodilation and salivary flow by regulating peptide release and second messenger systems for both VIP and acetylcholine, as has been shown in pigs and rats (35-37). As described in the present study, the elements of the L-arginine/NO-generating pathways are also found in human salivary glands and saliva.
There were some interesting differences between the SS patients and controls. The increase in NO,-seen in SS may have been related to an inflammation-induced increase in the expression of the iNOS rather than to the increased activity of the cNOS isoforms. The increased salivary NOz-concentration is not likely to be a reflection of the decreased "water" content of the saliva, because the salivary NO2-output was also significantly higher in the SS patients than in the controls. Furthermore, a decrease in the salivary gland tissue mass, e.g., by replacement with inflammatory cell infiltrates, fibrosis, and fat atrophy, would lead to an apparently low salivary NO2-concentration, so that a 50% decrease in the mass would decrease the salivary NO2-concentration/output by half. Perhaps even more importantly, deranged architecture/function of the diseased glandular tissue would also contribute to an apparently low salivary NO,-concentration/output, so that a 50% decrease in the function would also decrease the salivary NO,-concentration/output by half. Therefore, the observed differences between patients and controls may reflect quite significant differences in the salivary gland tissues.
Studies in pigs have demonstrated that release of VIP from the salivary gland, elicited by parasympathetic stimulation (10 Hz, 30 seconds), was markedly reduced by a NOS inhibitor, p-nitro-L-arginine (36,37). Interestingly, in the present study, no significant correlations were found between the salivary NO,-and VIP concentrations, suggesting that this NO-mediated regulation of VIP release may not be the only system controlling VIP release from the peripheral VIPergic nerve fibers in human salivary glands.
In addition to the constitutively expressed and rapidly regulated endothelial and neuronal NOS, iNOS has been described in numerous cell types. However, the presence of iNOS in human macrophages is still a matter of controversy (38,39). The iNOS gene is located in chromosome 7, and its level of expression is regulated by various cytokines and lipopolysaccharides. In particular, certain cytokine combinations, such as interferon-y (IFNy), interleukin-1 (IL-l), and TNFa, are very effective and synergistic in the up-regulation of iNOS gene expression (40,41). Inducible NOS produces high concentrations of NO for extended time periods, and, often, high cytotoxic and bactericidal concentrations of NO are produced.
Increased NO production hardly represents attempts to compensate for diminished cholinergic stimulation. It seems that the increased NO production is caused by local inflammatory changes and by cytokines, and, as such, appears to be an effect of inflammation rather than of a physiologic process intended to compensate for diminished cholinergic Stimulation. Moreover, increased inflammatory NO production mediated by iNOS might not be able to compensate for the highly regulated neuronal events that are involved in the coordinated vascular, motor, and secretory components of the reflex salivary flow. Inflammatory NO production would be very unlikely to have that type of effect, coordinated in time and at site, that is characteristic of a well-functioning normal neurovascular system of the salivary gland.
It was of particular interest to note that NADPHdiaphorase activity and, to a lesser extent, iNOS expression, were seen in the acinar and ductal epithelial cells of LSGs from SS patients, but also to some extent in those from healthy controls. In thyroid glands, NADPHdiaphorase activity and NOS immunoreactivity have been described in nerve fibers and vascular endothelium, but not in the glandular parenchymal cells (42). Lohinai and coworkers, in a study of feline submandibular glands, noticed that the epithelial layer of the salivary ductal branches was NOS immunonegative, but NADPHdiaphorase positive (34). Inducible NOS/NADPHdiaphorase in salivary glands might be induced by bacterial lipopolysaccharides (40). However, considering the cytokine-mediated regulation of iNOS, it seems more likely that in SS, iNOS immunoreactivity and NADPH-diaphorase activity are induced by cytokines, such as TNFa, IL-1, and IFNy (40,41), which are produced by the salivary gland epithelial cells and/or activated T lymphocytes (43-45).
One interesting feature of the minor salivary glands is the occurrence of focal accumulations of lymphocytes around the duct walls (46-48), which are believed to have a role in the immune surveillance of the mouth (48). Although the control LSGs were from subjects who did not have SS and who had a focus score (10) of 4 , they did have occasional lymphocyte foci. These foci might produce enough cytokines (43-45) to up-regulate the iNOS immunoreactivity/NADPHdiaphorase activity even in normal minor salivary glands, although not to the same extent as in SS, as suggested by the present findings on salivary NOz-concentration.
The salivary concentration of NO2-may not quite reflect the extent of local NO production, because at least part of the locally produced NO could be disposed via pathways other than that leading to saliva. It is therefore possible that the increased, inflammationassociated, and probably cytokine-induced local NO production in SS interferes with the normal function of the cNOS isoforms and may, by itself, lead to cytopathic changes and acinar cell atrophy.
Thus, NO is produced in physiologic amounts in normal salivary glands mainly by constitutively expressed ncNOS and ecNOS isoforms, and may contribute to various events that regulate vascular reactivity, salivary flow, and neuropeptide release. In focal adenitis in SS, cytokine-induced iNOS is expressed by salivary gland acinar and ductal epithelial cells together with TNFa, suggesting a role for these resident cells in local pathomechanisms, which may contribute to various cytopathic and atrophic cell changes.
